iPSC-derived type IV collagen α5-expressing kidney organoids model Alport syndrome.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
28 Sep 2023
Historique:
received: 27 08 2022
accepted: 02 08 2023
medline: 20 11 2023
pubmed: 29 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

Alport syndrome (AS) is a hereditary glomerulonephritis caused by COL4A3, COL4A4 or COL4A5 gene mutations and characterized by abnormalities of glomerular basement membranes (GBMs). Due to a lack of curative treatments, the condition proceeds to end-stage renal disease even in adolescents. Hampering drug discovery is the absence of effective in vitro methods for testing the restoration of normal GBMs. Here, we aimed to develop kidney organoid models from AS patient iPSCs for this purpose. We established iPSC-derived collagen α5(IV)-expressing kidney organoids and confirmed that kidney organoids from COL4A5 mutation-corrected iPSCs restore collagen α5(IV) protein expression. Importantly, our model recapitulates the differences in collagen composition between iPSC-derived kidney organoids from mild and severe AS cases. Furthermore, we demonstrate that a chemical chaperone, 4-phenyl butyric acid, has the potential to correct GBM abnormalities in kidney organoids showing mild AS phenotypes. This iPSC-derived kidney organoid model will contribute to drug discovery for AS.

Identifiants

pubmed: 37770589
doi: 10.1038/s42003-023-05203-4
pii: 10.1038/s42003-023-05203-4
pmc: PMC10539496
doi:

Substances chimiques

Collagen Type IV 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

854

Subventions

Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP23bm1123002
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP22bm0804013

Informations de copyright

© 2023. The Author(s).

Références

Virchows Arch A Pathol Anat Histol. 1974;364(3):225-33
pubmed: 4219460
Genes (Basel). 2022 Oct 18;13(10):
pubmed: 36292778
Nat Rev Nephrol. 2021 Feb;17(2):112-127
pubmed: 32839582
Am J Physiol Renal Physiol. 2021 Jul 1;321(1):F12-F25
pubmed: 34029143
Biochem Biophys Res Commun. 2004 Dec 3;325(1):276-80
pubmed: 15522229
Elife. 2022 Jan 25;11:
pubmed: 35076391
Pediatr Nephrol. 1998 Sep;12(7):554-8
pubmed: 9761353
Biochem Biophys Rep. 2018 Dec 12;17:81-86
pubmed: 30582011
J Cell Biol. 1994 Nov;127(3):879-91
pubmed: 7962065
Nat Biotechnol. 2015 Nov;33(11):1193-200
pubmed: 26458176
J Cell Biol. 1985 Jun;100(6):1988-2000
pubmed: 3889015
Stem Cells. 2013 Mar;31(3):458-66
pubmed: 23193063
Stem Cell Reports. 2021 Apr 13;16(4):985-996
pubmed: 33711268
Sci Rep. 2014 Jan 08;4:3594
pubmed: 24399248
Kidney Int Rep. 2017 Mar 27;2(4):739-748
pubmed: 29142990
Cell Stem Cell. 2014 Jan 2;14(1):53-67
pubmed: 24332837
STAR Protoc. 2021 Nov 16;2(4):100965
pubmed: 34825222
Stem Cell Reports. 2018 Mar 13;10(3):766-779
pubmed: 29429961
Nat Protoc. 2021 Feb;16(2):579-602
pubmed: 33328611
Int J Cancer. 1997 Jul 3;72(1):43-9
pubmed: 9212221
Nature. 2015 Oct 22;526(7574):564-8
pubmed: 26444236
Am J Physiol Renal Physiol. 2019 May 1;316(5):F830-F837
pubmed: 30724107
EBioMedicine. 2021 Jan;63:103162
pubmed: 33340991
J Am Soc Nephrol. 2010 May;21(5):876-83
pubmed: 20378821
Nat Protoc. 2012 Nov;7(11):2029-40
pubmed: 23099485
Hum Mol Genet. 1994 Aug;3(8):1269-73
pubmed: 7987301
Skelet Muscle. 2011 Mar 01;1(1):9
pubmed: 21798088
J Med Assoc Thai. 2006 Nov;89 Suppl 5:S171-81
pubmed: 17718259
Nephrol Dial Transplant. 2006 Nov;21(11):3146-54
pubmed: 16940319
Kidney Int. 2014 May;85(5):1208-13
pubmed: 24304881
Kidney Int. 2003 Dec;64(6):1986-96
pubmed: 14633121
Lab Invest. 1972 Nov;27(5):473-87
pubmed: 4653971
J Am Soc Nephrol. 2014 May;25(5):939-51
pubmed: 24436468
Kidney Int. 1992 Jul;42(1):115-26
pubmed: 1635341
Kidney Int. 2020 Dec;98(6):1605-1614
pubmed: 32712167
J Am Soc Nephrol. 2004 Jun;15(6):1466-74
pubmed: 15153557
Cell. 2016 May 19;165(5):1238-1254
pubmed: 27118425
J Clin Invest. 1997 May 15;99(10):2470-8
pubmed: 9153291
Pediatr Nephrol. 2000 Jun;14(6):502-12
pubmed: 10872195
Hum Mol Genet. 2014 Jan 15;23(2):283-92
pubmed: 24001601
Pharmacol Res. 2016 May;107:205-210
pubmed: 26995302
Kidney Int. 1999 Dec;56(6):2016-24
pubmed: 10594777
J Cell Biol. 1996 Dec;135(5):1403-13
pubmed: 8947561
Cell Chem Biol. 2018 May 17;25(5):634-643.e4
pubmed: 29526710
Science. 1990 Jun 8;248(4960):1224-7
pubmed: 2349482
Nephrol Dial Transplant. 1997 Aug;12(8):1595-9
pubmed: 9269635
Nat Commun. 2018 Dec 4;9(1):5167
pubmed: 30514835
Cell Stem Cell. 2019 Apr 4;24(4):566-578.e7
pubmed: 30853558
J Cell Sci. 2015 May 1;128(9):1661-8
pubmed: 25717004
Matrix Biol. 2010 Jun;29(5):346-56
pubmed: 20307660
Am J Pathol. 1972 Nov;69(2):213-24
pubmed: 4343992
Am J Pathol. 2003 Mar;162(3):873-85
pubmed: 12598321
Cell Rep. 2020 Apr 7;31(1):107476
pubmed: 32268094
Pediatr Nephrol. 2017 Jan;32(1):131-137
pubmed: 27402170
J Am Soc Nephrol. 2016 Jan;27(1):144-57
pubmed: 25967122

Auteurs

Ryuichiro Hirayama (R)

Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan.
Taisho Pharmaceutical Co., Ltd., Saitama, 331-9530, Japan.

Kosuke Toyohara (K)

Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan.

Kei Watanabe (K)

Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan.

Takeya Otsuki (T)

Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan.

Toshikazu Araoka (T)

Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan.

Shin-Ichi Mae (SI)

Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan.

Tomoko Horinouchi (T)

Department of Pediatrics, Kobe University Graduate School of Medicine, Hyogo, 650-0017, Japan.

Tomohiko Yamamura (T)

Department of Pediatrics, Kobe University Graduate School of Medicine, Hyogo, 650-0017, Japan.

Keisuke Okita (K)

Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan.

Akitsu Hotta (A)

Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan.

Kazumoto Iijima (K)

Department of Pediatrics, Kobe University Graduate School of Medicine, Hyogo, 650-0017, Japan.
Hyogo Prefectural Kobe Children's Hospital, Hyogo, 650-0047, Japan.
Department of Advanced Pediatric Medicine, Kobe University Graduate School of Medicine, Hyogo, 650-0017, Japan.

Kandai Nozu (K)

Department of Pediatrics, Kobe University Graduate School of Medicine, Hyogo, 650-0017, Japan.

Kenji Osafune (K)

Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan. osafu@cira.kyoto-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH